Enrolling by invitationNo phase
Follows children with juvenile inflammatory rheumatism over time
Follows children with juvenile arthritis to study treatment safety and benefit.
Plain-language title generated from the registry record
Registry title: Juvenile Inflammatory Rheumatism (JIR) Cohorte
Key facts
- Where
- Brussels, Charleroi, Leuven, and Liège, BelgiumSee the 5 sites
Where in Belgium
- Hôpital Reine FabiolaBrussels, BelgiumNo longer taking part
- CHU CharleroiCharleroi, BelgiumNo longer taking part
- UZ LeuvenLeuven, BelgiumNo longer taking part
- CHC LiegeLiège, BelgiumNo longer taking part
- CHR CitadelleLiège, BelgiumNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Michaël Hofer
- Trial code
- NCT02377245
- Record updated
- 15 June 2023
- Original description
The investigators created a cohort of patients with juvenile inflammatory rheumatisms with the purpose to follow them prospectively, and investigate the tolerance and efficacy of immunosuppresive and biological agents.Read full original descriptionShow less
Setting up a Pediatric Cohort for Inflammatory Rheumatic Diseases
The investigators created a cohort of patients with juvenile inflammatory rheumatisms with the purpose to follow them prospectively, and investigate the tolerance and efficacy of immunosuppresive and biological agents.
Inclusion: Patients with juvenile inflammatory diseases; Age at onset up to 18 years old; Consent according national codes of ethics and current laws.
Exclusion: Non-consent from patients and/or legal representative.